Cargando…

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland

We evaluated the cost-effectiveness of capsaicin 8% patch (QUTENZA™) versus pregabalin in patients with PNP from the perspective of the National Health Service (NHS) and Personal and Social Services in Scotland, UK. A decision-tree cost-effectiveness model was developed for non-diabetic patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mankowski, Colette, Patel, Sachin, Trueman, David, Bentley, Anthony, Poole, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794144/ https://www.ncbi.nlm.nih.gov/pubmed/26983018 http://dx.doi.org/10.1371/journal.pone.0150973

Ejemplares similares

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
por: Mankowski, Colette, et al.
Publicado: (2017)

Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain
por: Cruccu, G., et al.
Publicado: (2017)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014)

The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis
por: Wagner, Till, et al.
Publicado: (2013)

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
por: Huygen, Frank, et al.
Publicado: (2020)

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
por: Peppin, John F, et al.
Publicado: (2011)

Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain
por: Giaccari, Luca Gregorio, et al.
Publicado: (2021)

Peripheral Neuropathic Pain Following Breast Cancer: Effectiveness and Tolerability of High-Concentration Capsaicin Patch
por: Dupoiron, Denis, et al.
Publicado: (2022)

Pain‐relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice
por: Hansson, P., et al.
Publicado: (2018)

Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: A multicentre, randomized, assessor-blinded study
por: Jensen, TS, et al.
Publicado: (2014)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability
por: Laklouk, Muhammad, et al.
Publicado: (2016)

Vaccination Granuloma Itch Treated with Capsaicin 8% Patches
por: HOFFMANN, Stine, et al.
Publicado: (2020)

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain
por: Webster, Lynn R, et al.
Publicado: (2012)

Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications
por: Freynhagen, Rainer, et al.
Publicado: (2021)

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
por: Sicras‐Mainar, Antoni, et al.
Publicado: (2016)

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups
por: Martini, Christian, et al.
Publicado: (2012)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012)

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
por: Freynhagen, Rainer, et al.
Publicado: (2015)

High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience
por: Filipczak-Bryniarska, Iwona, et al.
Publicado: (2017)

Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
por: Laude-Pagniez, Eulalie, et al.
Publicado: (2022)

Retraction: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2014)

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
por: Anand, P., et al.
Publicado: (2011)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain
por: Light, Allison, et al.
Publicado: (2017)

The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
por: Wang, Bruce C. M., et al.
Publicado: (2016)

Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification
por: Anand, Praveen, et al.
Publicado: (2019)

Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center
por: Bienfait, Florent, et al.
Publicado: (2023)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials
por: Freeman, Roy, et al.
Publicado: (2015)

Neuronal hyperexcitability in the ventral posterior thalamus of neuropathic rats: modality selective effects of pregabalin
por: Patel, Ryan, et al.
Publicado: (2016)

A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings
por: Navarro, Ana, et al.
Publicado: (2011)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

Topical Capsaicin for the Treatment of Sensory Neuropathic Cough
por: Hoesli, Rebecca C., et al.
Publicado: (2021)

Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes
por: Papagianni, Aikaterini, et al.
Publicado: (2018)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study
por: Maihöfner, CG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2con3028on18ib6o9qe9c3m1qh